Intellia Therapeutics' Q1 Cash, Cash Equivalents And Marketable Securities Were $953.4M Expected To Provide Cash Runway Into Late 2026
Intellia Therapeutics第一季度現金、現金等價物和有價證券預計爲9.534億美元,將在2026年底之前提供現金流
Intellia Therapeutics' Q1 Cash, Cash Equivalents And Marketable Securities Were $953.4M Expected To Provide Cash Runway Into Late 2026
Intellia Therapeutics第一季度現金、現金等價物和有價證券預計爲9.534億美元,將在2026年底之前提供現金流
使用瀏覽器的分享功能,分享給你的好友吧